Literature DB >> 29192862

Clinicoradiological features of intraneural perineuriomas obviate the need for tissue diagnosis.

Thomas J Wilson1, B Matthew Howe2, Shelby A Stewart2, Robert J Spinner3, Kimberly K Amrami2.   

Abstract

OBJECTIVE: This study aimed to define a set of clinicoradiological parameters with a high specificity for the diagnosis of intraneural perineurioma, obviating the need for operative tissue diagnosis.
METHODS: The authors retrospectively reviewed MR images obtained in a large cohort of patients who underwent targeted fascicular biopsy and included only those patients for whom the biopsy yielded a diagnosis. Clinical and radiological findings were then tested for their ability to predict a tissue diagnosis of intraneural perineurioma. The authors propose a new set of diagnostic criteria, referred to as the Perineurioma Diagnostic Criteria. The sensitivity, specificity, positive predictive value, and negative predictive value of several clinicoradiological methods of diagnosis were compared.
RESULTS: A total of 195 patients who underwent targeted fascicular biopsy were included in the cohort, of whom 51 had a tissue diagnosis of intraneural perineurioma. When the clinicoradiological methods used in this study were compared, the highest sensitivity (0.86), negative predictive value (0.95), and F1 score (0.88) were observed for the decision trees generated in C5.0 and rPart, whereas the highest specificity (1.0) and positive predictive value (1.0) were observed for the Perineurioma Diagnostic Criteria.
CONCLUSIONS: This study identified clinical and radiological features that are associated with a diagnosis of perineurioma. The Perineurioma Diagnostic Criteria were determined to be the following: 1) no cancer history, 2) unifocal disease, 3) moderate to severe hyperintensity on T2-weighted MR images, 4) moderate to severe contrast enhancement, 5) homogeneous contrast enhancement, 6) fusiform shape, 7) enlargement of the involved nerves, and 8) age ≤ 40 years. Use of the Perineurioma Diagnostic Criteria obviates the need for tissue diagnosis when all of the criteria are satisfied.

Entities:  

Keywords:  EMA = epithelial membrane antigen; fascicular biopsy; perineurioma; peripheral nerve

Mesh:

Substances:

Year:  2017        PMID: 29192862     DOI: 10.3171/2017.5.JNS17905

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Diffusion-weighted imaging and diffusion tensor imaging as adjuncts to conventional MRI for the diagnosis and management of peripheral nerve sheath tumors: current perspectives and future directions.

Authors:  Alexander T Mazal; Oganes Ashikyan; Jonathan Cheng; Lu Q Le; Avneesh Chhabra
Journal:  Eur Radiol       Date:  2018-12-07       Impact factor: 5.315

Review 2.  Ultrasound and MR imaging of peripheral nerve tumors: the state of the art.

Authors:  Guillaume Lefebvre; Thomas Le Corroller
Journal:  Skeletal Radiol       Date:  2022-06-17       Impact factor: 2.199

3.  BPNSTs: In the eye of the beholder.

Authors:  Timothy J Kaufmann; Bradley J Erickson
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 12.300

4.  Machine learning approach to differentiation of peripheral schwannomas and neurofibromas: A multi-center study.

Authors:  Michael Zhang; Elizabeth Tong; Sam Wong; Forrest Hamrick; Maryam Mohammadzadeh; Vaishnavi Rao; Courtney Pendleton; Brandon W Smith; Nicholas F Hug; Sandip Biswal; Jayne Seekins; Sandy Napel; Robert J Spinner; Mark A Mahan; Kristen W Yeom; Thomas J Wilson
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

Review 5.  Neuropathy Score Reporting and Data System (NS-RADS): MRI Reporting Guideline of Peripheral Neuropathy Explained and Reviewed.

Authors:  Avneesh Chhabra; Swati D Deshmukh; Amelie M Lutz; Jan Fritz; Darryl B Sneag; Bayan Mogharrabi; Mina Guirguis; Gustav Andreisek; Yin Xi; Shivani Ahlawat
Journal:  Skeletal Radiol       Date:  2022-04-27       Impact factor: 2.128

6.  Modern treatment of perineuriomas: a case-series and systematic review.

Authors:  Anne-Kathrin Uerschels; Christos Krogias; Andreas Junker; Ulrich Sure; Karsten H Wrede; Oliver Gembruch
Journal:  BMC Neurol       Date:  2020-02-13       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.